Teng YKO - Search Results

1

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome.

Wind M, Hendriks M, van Brussel BTJ, Eikenboom J, Allaart CF, Lamb HJ, Siebelink HJ, Ninaber MK, van Geloven N, van Lith JMM, Huizinga TWJ, Rabelink TJ, Sueters M, Teng YKO. Wind M, et al. Among authors: teng yko. Lupus Sci Med. 2021 May;8(1):e000472. doi: 10.1136/lupus-2020-000472. Lupus Sci Med. 2021. PMID: 33952625 Free PMC article.

2

Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.

Teng YK, Verburg RJ, Verpoort KN, Diepenhorst GM, Bajema IM, van Tol MJ, Jol-van der Zijde EC, Toes RE, Huizinga TW, van Laar JM. Teng YK, et al. Arthritis Res Ther. 2007;9(5):R106. doi: 10.1186/ar2309. Arthritis Res Ther. 2007. PMID: 17927821 Free PMC article.

3

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.

Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM. Teng YK, et al. Arthritis Rheum. 2007 Dec;56(12):3909-18. doi: 10.1002/art.22967. Arthritis Rheum. 2007. PMID: 18050222 Free article.

4

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.

Teng YK, Wheater G, Hogan VE, Stocks P, Levarht EW, Huizinga TW, Toes RE, van Laar JM. Teng YK, et al. Arthritis Res Ther. 2012 Mar 12;14(2):R57. doi: 10.1186/ar3770. Arthritis Res Ther. 2012. PMID: 22409963 Free PMC article. Clinical Trial.

5

Belimumab after rituximab as maintenance therapy in lupus nephritis.

Kraaij T, Huizinga TW, Rabelink TJ, Teng YK. Kraaij T, et al. Rheumatology (Oxford). 2014 Nov;53(11):2122-4. doi: 10.1093/rheumatology/keu369. Epub 2014 Sep 8. Rheumatology (Oxford). 2014. PMID: 25205827 No abstract available.

6

A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes.

Kraaij T, Tengström FC, Kamerling SW, Pusey CD, Scherer HU, Toes RE, Rabelink TJ, van Kooten C, Teng YK. Kraaij T, et al. Autoimmun Rev. 2016 Jun;15(6):577-84. doi: 10.1016/j.autrev.2016.02.018. Epub 2016 Feb 27. Autoimmun Rev. 2016. PMID: 26925759 Free article. Review.

7

C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.

van Schaarenburg RA, Magro-Checa C, Bakker JA, Teng YK, Bajema IM, Huizinga TW, Steup-Beekman GM, Trouw LA. van Schaarenburg RA, et al. Front Immunol. 2016 Dec 27;7:647. doi: 10.3389/fimmu.2016.00647. eCollection 2016. Front Immunol. 2016. PMID: 28082982 Free PMC article.

8

TAC-TIC use of tacrolimus-based regimens in lupus nephritis.

Kraaij T, Bredewold OW, Trompet S, Huizinga TW, Rabelink TJ, de Craen AJ, Teng YK. Kraaij T, et al. Lupus Sci Med. 2016 Dec 29;3(1):e000169. doi: 10.1136/lupus-2016-000169. eCollection 2016. Lupus Sci Med. 2016. PMID: 28123768 Free PMC article. Review.

9

Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome.

Rijnink EC, Teng YK, Kraaij T, Wolterbeek R, Bruijn JA, Bajema IM. Rijnink EC, et al. Nephrol Dial Transplant. 2017 Apr 1;32(4):654-662. doi: 10.1093/ndt/gfx020. Nephrol Dial Transplant. 2017. PMID: 28340077

10

An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus.

Teng YKO, Bredewold EOW, Rabelink TJ, Huizinga TWJ, Eikenboom HCJ, Limper M, Fritsch-Stork RDE, Bloemenkamp KWM, Sueters M. Teng YKO, et al. Rheumatology (Oxford). 2018 Oct 1;57(10):1707-1720. doi: 10.1093/rheumatology/kex374. Rheumatology (Oxford). 2018. PMID: 29165607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page